What is Lenvatinib: Uses, Dosage, Side Effects and More

Lenvatinib is a targeted cancer medication that blocks specific proteins helping cancer cells grow and spread. This oral medication belongs to a group called tyrosine kinase inhibitors, which work like molecular switches to slow down cancer progression. Your doctor might prescribe lenvatinib if you have certain types of thyroid cancer, liver cancer, or kidney cancer that hasn't responded well to other treatments.

What is Lenvatinib?

Lenvatinib is a prescription cancer medication that comes as capsules you take by mouth. It's designed to target and block specific pathways that cancer cells use to grow, multiply, and form new blood vessels. Think of it as a precision tool that interferes with cancer's ability to thrive in your body.

This medication is part of a newer generation of cancer treatments called targeted therapy. Unlike traditional chemotherapy that affects all rapidly dividing cells, lenvatinib focuses on specific proteins found mainly in cancer cells. This targeted approach often means fewer side effects compared to older cancer treatments.

What is Lenvatinib Used For?

Lenvatinib treats several specific types of advanced cancer when other treatments haven't worked effectively. Your oncologist will determine if this medication is right for your particular situation based on your cancer type, stage, and overall health.

The main conditions lenvatinib treats include advanced thyroid cancer that no longer responds to radioactive iodine treatment. It's also used for advanced liver cancer (hepatocellular carcinoma) and advanced kidney cancer (renal cell carcinoma) when used alongside another medication called everolimus.

Your doctor might also prescribe lenvatinib for certain types of endometrial cancer that has spread or returned after other treatments. Each of these uses requires careful evaluation to ensure the benefits outweigh the risks for your specific situation.

How Does Lenvatinib Work?

Lenvatinib works by blocking multiple proteins that cancer cells need to survive and grow. It's considered a moderately strong cancer medication that targets several pathways simultaneously. The medication specifically blocks proteins called VEGFR, FGFR, and others that help cancer cells form new blood vessels and multiply.

When lenvatinib blocks these proteins, it cuts off the cancer's blood supply and slows its ability to grow and spread. This process is called anti-angiogenesis, which means preventing the formation of new blood vessels that feed tumors. The medication also directly interferes with cancer cell division and survival.

The multi-targeted approach makes lenvatinib effective against cancers that have become resistant to single-pathway treatments. However, this broad action also means it can affect normal cells that use these same pathways, which explains why side effects can occur.

How Should I Take Lenvatinib?

Take lenvatinib exactly as your doctor prescribes, usually once daily at the same time each day. You can take it with or without food, but try to be consistent with your choice. Swallow the capsules whole with a full glass of water - don't crush, chew, or open them.

If you have trouble swallowing capsules, you can open them and mix the contents with a small amount of water or apple juice. Drink the mixture immediately and rinse the container with more liquid to get all the medication. Never save this mixture for later use.

Taking lenvatinib on an empty stomach might help reduce nausea for some people, while others find it easier to tolerate with food. Pay attention to how your body responds and discuss any concerns with your healthcare team. They can help you find the best approach for your situation.

How Long Should I Take Lenvatinib For?

You'll likely take lenvatinib for as long as it's helping control your cancer and you're tolerating it reasonably well. This could be months or even years, depending on how your cancer responds to treatment. Your doctor will monitor your progress through regular scans and blood tests.

The duration of treatment varies greatly from person to person based on factors like cancer type, how well the medication is working, and what side effects you experience. Some people take lenvatinib for many months with good results, while others might need dose adjustments or breaks from treatment.

Your oncologist will regularly assess whether continuing lenvatinib is the best option for you. They'll consider factors like tumor response, side effects, and your overall quality of life. Never stop taking lenvatinib without discussing it with your doctor first, as sudden discontinuation could allow cancer to progress more quickly.

What Are the Side Effects of Lenvatinib?

Lenvatinib can cause various side effects because it affects multiple pathways in your body, not just cancer cells. Most people experience some side effects, but they're often manageable with proper support and sometimes dose adjustments. Your healthcare team will work closely with you to minimize these effects.

Common side effects that many people experience include fatigue, high blood pressure, diarrhea, and decreased appetite. You might also notice weight loss, nausea, joint pain, or changes in your voice. These effects often improve as your body adjusts to the medication or with supportive treatments.

Some people develop hand-foot syndrome, which causes redness, swelling, and pain on the palms and soles. Mouth sores, headaches, and stomach pain are also possible. Your doctor will monitor you closely and can recommend ways to manage these symptoms effectively.

Less common but more serious side effects can include heart problems, severe bleeding, or kidney issues. Your healthcare team will watch for these through regular blood tests and check-ups. Contact your doctor immediately if you experience chest pain, unusual bleeding, or difficulty breathing.

Rare but serious side effects include liver problems, which your doctor will monitor through blood tests, and potentially serious heart rhythm changes. Some people might develop blood clots or experience severe fatigue that interferes with daily activities. These effects require immediate medical attention.

Who Should Not Take Lenvatinib?

Lenvatinib isn't suitable for everyone, and certain medical conditions or situations make it unsafe to use. Your doctor will carefully review your medical history and current health status before prescribing this medication. Being honest about your complete medical picture helps ensure your safety.

You shouldn't take lenvatinib if you're pregnant or breastfeeding, as it can harm a developing baby. If you're of childbearing age, you'll need to use effective birth control during treatment and for some time after stopping the medication. Men should also use contraception during treatment.

People with certain heart conditions, severe liver problems, or a history of bleeding disorders might not be candidates for lenvatinib. If you have uncontrolled high blood pressure, recent heart attack, or significant kidney disease, your doctor will need to evaluate the risks and benefits carefully.

Those with active bleeding, recent surgery, or wound healing problems should discuss these conditions with their oncologist. Previous allergic reactions to lenvatinib or similar medications also make this treatment inappropriate.

Lenvatinib Brand Name

Lenvatinib is sold under the brand name Lenvima in most countries, including the United States. This brand name helps distinguish it from other cancer medications and ensures you're getting the correct prescription. Always check that your pharmacy has given you the right medication by verifying both the generic and brand names.

Lenvima capsules come in different strengths, and your doctor will prescribe the specific dose that's right for your situation. The capsules are usually identifiable by their distinctive colors and markings. If your medication looks different than expected, check with your pharmacist before taking it.

Lenvatinib Alternatives

Several other targeted cancer medications work similarly to lenvatinib, though each has its own specific uses and effects. Your oncologist might consider alternatives if lenvatinib isn't suitable for you or if your cancer doesn't respond well to it. The choice depends on your specific cancer type and individual circumstances.

For thyroid cancer, alternatives might include sorafenib (Nexavar), which also blocks multiple cancer pathways but with a different side effect profile. Cabozantinib (Cabometyx) is another option that targets similar pathways and might be suitable for certain situations.

For liver cancer, sorafenib has been a standard treatment, though lenvatinib has shown similar effectiveness with different side effects. Regorafenib (Stivarga) might be an option for people whose cancer progresses on other treatments.

In kidney cancer, other targeted therapies like sunitinib (Sutent), pazopanib (Votrient), or newer immunotherapy combinations might be alternatives. Your oncologist will consider factors like your previous treatments, overall health, and specific cancer characteristics when discussing options.

Is Lenvatinib Better Than Sorafenib?

Lenvatinib and sorafenib are both effective targeted cancer medications, but they work slightly differently and have different side effect profiles. Neither is universally "better" than the other - the best choice depends on your specific cancer type, overall health, and how well you tolerate each medication.

For thyroid cancer, studies suggest lenvatinib might be more effective at shrinking tumors compared to sorafenib. However, lenvatinib may cause more side effects like high blood pressure and fatigue, while sorafenib is more likely to cause skin problems and diarrhea.

In liver cancer, both medications have shown similar overall survival benefits, but lenvatinib might work better for certain people while sorafenib suits others better. Your oncologist will consider your individual factors like liver function, other health conditions, and lifestyle when making this decision.

The choice between these medications often comes down to which side effects you're more likely to tolerate and manage effectively. Your healthcare team can help you understand the pros and cons of each option based on your specific situation.